COMPANY PROFILE

Varinos

Explore full profile

Offering advanced clinical tests in reproductive medicine and obstetrics/gynecology

Tokyo, JapanFounded 2017Biotech & Life Sciences

Valuation $0–100M Latest valuation · 2026

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Varinos

Varinos Inc. is a pioneering company in the field of genomics and genetics, focusing on providing advanced clinical tests based on genome technology. The company primarily serves individuals and healthcare providers, aiming to address fertility challenges and optimize treatment choices through comprehensive genomic information. Operating in the healthcare and biotechnology market, Varinos utilizes next-generation sequencing (NGS) technology to read thousands to millions of DNA sequences at high speed. This enables the company to offer precise and personalized medical solutions. Varinos generates revenue by offering genomic tests and providing support to doctors in interpreting the results, thereby enhancing patient care. The company's business model revolves around the commercialization of these genomic tests and the continuous development of new genomic solutions.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Tokyo, Japan
Employees: 12
Open positions: None listed
Dealroom signal: 71.8/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Precision Medicine, Spinout, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Latest news

Press, funding announcements and product moves mentioning Varinos.

See all news

Funding history

7 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
DEBT✓Debt	May 2026	$0	—	Shizuoka Bank · Shoko Chukin Bank · Joyo Bank · Higashi-Nippon Bank	↗
SERIES D✓Equity / VC	May 2026	$9.6M	$38M	Yokohama Capital · Mitsui Chemicals · Mirai Souzou	↗

Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Varinos website traffic

Latest recorded traffic for Varinos is 19K monthly website visits, down 5% over the last three months. Varinos's team grew 0% over the past year.

Latest monthly visits19K 3-month web change-5% 1-year team growth0%

Monthly website visitsMay 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
DBDelve BioProviding Molecular Insights for the Precision Care of the Sickest Patients	Boston, United States	Operational	43	$71M	$140M
TBTome BiosciencesTome Biosciences is the programmable gene insertion company	Watertown, United States	Operational
ATAtG TherapeuticsAt AtG, we develop novel classes of medicines and biomarkers to prevent cancer therapeutic resistance	L'Hospitalet de Llobregat, Spain	Operational
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational
TTTime TherapeuticsDeveloping treatments for intractable diseases using patient iPS cells	Kyoto, Japan	Operational
XIXilisDeveloping next generation technologies for precision medicine and drug discovery	Durham, United States	Operational
NTNucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine	Oxford, United Kingdom	Operational
EBEisbach BioInnovative start-up in biotechnology developing novel drugs that successfully target molecular vulnerabilities arising in cancer genomes	Planegg, Germany	Operational